India's Pharmaceutical Exports

Country Profile

United Arab Emirates

United Arab Emirates is a major destination for Indian pharmaceutical exports — $374M in FY 2025–26, with 3.8× growth over the past decade. Medicines accounts for 55% of shipments, with vaccines contributing $1.86M. The compound annual growth rate since FY2015 stands at 12.9%.

🇦🇪 #15 Destination · $374M · 3.8× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$374M
Exports FY2025–26 DGCIS
3.8×
Growth FY2015→2026
1.2%
Share of India Total
#15
Rank Among 178 Markets
12.9%
CAGR FY2015→2026
United Arab Emirates is a major destination for Indian pharmaceutical exports — $374M in FY 2025–26, with 3.8× growth over the past decade. Medicines accounts for 55% of shipments, with vaccines contributing $1.86M. The compound annual growth rate since FY2015 stands at 12.9%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $207M (55.4%) Medicine Ingredients $110M (29.5%) Traditional & Herbal $32.4M (8.7%) Surgical & Hospital Supplies $22.3M (6.0%) Vaccines $1.86M (0.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to United Arab Emirates in the RBI overseas direct investment dataset (2011–2026).